Abstract:Natural immunity, the first line for the body to defense against the invasion of pathogen, serves as the body's perception of the presence of pathogens depends on nucleic acid recognition mechanisms. The cyclic GMP-AMP synthase-stimulator of the interferon gene (cGAS-STING) signaling pathway is considered an essential pattern recognition and effector pathway in the natural immune system and is mainly responsible for recognizing DNA molecules present in the cytoplasm and activating downstream signaling pathways to generate type I interferons and some other inflammatory factors. STING, a crucial junction protein in the innate immune system, exerts an essential role in host resistance to external pathogen invasion. Also, STING, with the same character of inflammatory molecules, is inseparable from the body's inflammatory response. In particular, when the expression of STING is upregulated or its related signaling pathways are overactivated, the body may develop serious infectious disorders due to the generation of excessive inflammatory responses, non-infectious diseases, and autoimmune diseases. In recent years, accumulating studies indicated that the abnormal activation of the natural immune cGAS-STING signaling pathway modulated by the nucleic acid receptor cGAS closely associated with the development and occurrence of autoimmune diseases (AID). Thereof, to explore an in-depth role of STING and its related signaling pathways in the diseases associated with inflammation may be helpful to provide new avenues for the treatment of these diseases in the clinic. This article reviews the activation process of the cGAS-STING signaling pathways and its related important roles, and therapeutic drugs in AID, aiming to improve our understanding of AID and achieve better diagnosis and treatment of AID.

Inhibitory targeting cGAS-STING-TBK1 axis: Emerging strategies for autoimmune diseases therapy

cGAS-STING signaling pathway in gastrointestinal inflammatory disease and cancers

Small molecules targeting cGAS-STING pathway for autoimmune disease

Medicinal chemistry perspective on cGAS-STING signaling pathway with small molecule inhibitors

Development of small molecule inhibitors/agonists targeting STING for disease

Emerging role of the cGAS-STING signaling pathway in autoimmune diseases: Biologic function, mechanisms and clinical prospection

Small molecules targeting the innate immune cGAS‒STING‒TBK1 signaling pathway

Updated roles of cGAS-STING signaling in autoimmune diseases

The cGAS–STING pathway as a therapeutic target in inflammatory diseases

The role of the cGAS-STING signaling pathway in viral infections, inflammatory and autoimmune diseases

The triggers of the cGAS-STING pathway and the connection with inflammatory and autoimmune diseases

Agonists and Inhibitors of the Cgas-Sting Pathway

Advances in cGAS-STING Signaling Pathway and Diseases

Cgas–sting, an Important Signaling Pathway in Diseases and Their Therapy

Research Advances in How the cGAS-STING Pathway Controls the Cellular Inflammatory Response

The Cgas-Sting Pathway: Post-translational Modifications and Functional Implications in Diseases

The role of cGAS-STING signaling in rheumatoid arthritis: from pathogenesis to therapeutic targets

Regulation and function of the cGAS-MITA/STING axis in health and disease

Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy

cGAS-STING pathway in pathogenesis and treatment of osteoarthritis and rheumatoid arthritis

The cGAS–STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy